Regulatory news

Planned Management Team Changes

Amsterdam, The Netherlands, December 8, 2016 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments […]

08 December 2016

Read more